When did Veracyte report Q3 2025 earnings?

Veracyte (VCYT) reported Q3 2025 earnings on November 4, 2025 after market close.

What were Veracyte's Q3 2025 revenue and EPS?

Veracyte reported revenue of $131.9M and eps of $0.51 for Q3 2025.

Did Veracyte beat estimates in Q3 2025?

Revenue missed the consensus estimate of $135.8M by $3.9M. EPS beat the consensus estimate of $0.32 by $0.19.

How did Veracyte's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 13.8% from $115.9M a year earlier and eps grew 168.4% from $0.19.

Where can I find Veracyte's Q3 2025 SEC filings?

You can read the 8-K earnings release (0001384101-25-000128) and the 10-Q periodic report (0001384101-25-000130) directly on SEC EDGAR. The filing index links above go to sec.gov.

Veracyte VCYT Q3 2025 earnings

Reported November 4, 2025 · After market close

Revenue$131.9MMiss by $3.9M

EPS$0.51Beat by $0.19

Revenue estimate$135.8M

EPS estimate$0.32

Next report

Jul 30, 2026 (Tomorrow)

Revenue estimate$144.6M

EPS estimate$0.44

Financials

Q3 2025

Income statement

See full

Revenue$131.9M+13.8%

Gross profit$91.3M+15.5%

Operating income$22.9M+90.9%

Net income$19.1M+26.3%

EPS (diluted)$0.24+26.3%

Balance sheet

See full

Cash & equivalents$317.2M+15.3%

Total debt$40.5M+104%

Total equity$1.3B+6.9%

Total assets$1.4B+7.3%

Cash flow

See full

Operating cash flow$44.8M+49.4%

CapEx$2.8M+24.5%

Free cash flow$42.0M+51.4%

Valuation & ratios

Valuation

as of 09/30/25

See full

Market cap$2.7B+3.7%

Enterprise value$2.42B+3.2%

P/E89.1×—

P/S5.5×-0.7×

Profitability

See full

Gross margin68.5%+1.7pp

Operating margin5%+3.3pp

Net margin6.1%+4.8pp

FCF margin19.8%+6.6pp

Returns & leverage

See full

Return on equity2.5%+2.0pp

Debt / equity0×0.0×

Current ratio6.2×+1.2×

Segments

By segment

See full

Reportable Segment$131.9M+13.8%

By geography

See full

United States$124.1M+17.3%

By product

See full

Testing revenue$127.8M+16.6%

Versus estimates

Revenue

Q1 2026$139.1MBeat by $8.7M Q4 2025$140.6MBeat by $4.8M

Q3 2025$131.9MMiss by $3.9M

Q2 2025$130.2MBeat by $5.8M Q1 2025$114.5MBeat by $3.5M Q4 2024$118.6MBeat by $7.9M

Diluted EPS

Q1 2026$0.52Beat by $0.18 Q4 2025$0.53Beat by $0.12

Q3 2025$0.51Beat by $0.19

Q2 2025$0.44Beat by $0.13 Q1 2025$0.31Beat by $0.11 Q4 2024$0.36Beat by $0.26

Ask the moment Veracyte reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Veracyte report Q3 2025 earnings?: Veracyte (VCYT) reported Q3 2025 earnings on November 4, 2025 after market close.
What were Veracyte's Q3 2025 revenue and EPS?: Veracyte reported revenue of $131.9M and eps of $0.51 for Q3 2025.
Did Veracyte beat estimates in Q3 2025?: Revenue missed the consensus estimate of $135.8M by $3.9M. EPS beat the consensus estimate of $0.32 by $0.19.
How did Veracyte's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 13.8% from $115.9M a year earlier and eps grew 168.4% from $0.19.
Where can I find Veracyte's Q3 2025 SEC filings?: You can read the 8-K earnings release (0001384101-25-000128) and the 10-Q periodic report (0001384101-25-000130) directly on SEC EDGAR. The filing index links above go to sec.gov.